Business Segments · Depreciation
Biotechnology — Depreciation
Danaher Biotechnology — Depreciation increased by 2.6% to $39.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 2.6%, from $38.00M to $39.00M. Over 2 years (FY 2023 to FY 2025), Biotechnology — Depreciation shows relatively stable performance with a -4.1% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementSegment
CategoryEfficiency
SignalLower is better
VolatilityStable
First reportedQ1 2023
Last reportedQ4 2025
How to read this metric
High levels relative to revenue may indicate an aging asset base or high capital intensity.
Detailed definition
The systematic allocation of the cost of tangible fixed assets over their useful lives within the biotechnology segment....
Peer comparison
Commonly reported as part of segment-level operating expenses in industrial and life science companies.
Metric ID:
dhr_segment_biotechnology_depreciationHistorical Data
12 periods
| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $40.50M | $40.50M | $40.50M | $40.50M | $42.00M | $35.00M | $36.00M | $38.00M | $34.00M | $38.00M | $38.00M | $39.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +3.7% | -16.7% | +2.9% | +5.6% | -10.5% | +11.8% | +0.0% | +2.6% |
| YoY Change | — | — | — | — | +3.7% | -13.6% | -11.1% | -6.2% | -19.0% | +8.6% | +5.6% | +2.6% |
Range$34.00M – $42.00M
CAGR-1.4%
Avg YoY Growth-3.7%
Median YoY Growth-1.8%
Current Streak3 quarters growth
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Danaher's biotechnology — depreciation?
- Danaher (DHR) reported biotechnology — depreciation of $39.00M in Q4 2025.
- How has Danaher's biotechnology — depreciation changed year-over-year?
- Danaher's biotechnology — depreciation increased by 2.6% year-over-year, from $38.00M to $39.00M.
- What is the long-term trend for Danaher's biotechnology — depreciation?
- Over 2 years (2023 to 2025), Danaher's biotechnology — depreciation has grown at a -4.1% compound annual growth rate (CAGR), from $162.00M to $149.00M.
- What does biotechnology — depreciation mean?
- The non-cash expense representing the aging of physical assets in the biotechnology segment.